MeiraGTx up 5% after CEO sale filing
MeiraGTx Holdings plc gained in late-morning trading Wednesday, up 48 cents, or 5.3%, at $9.61. The move lifts the gene-therapy group’s market cap to around $781 million. The stock opened at $9.33 and touched $9.71 earlier in the session. President and CEO Alexandria Forbes sold 62,000 ordinary shares at a weighted average price of $9.17 on May 19, a day after an SEC Form 4 hit. The sale was made under a Rule 10b5-1 plan set up Nov. 18, 2025, the filing said. Forbes still holds 1,387,695 shares.